Antibiotic treatment of intra-amniotic infection with Ureaplasma urealyticum: A case report and literature review

Fetal Diagnosis and Therapy

Volumn 22, Issue 2, 2007, Pages 90-93

  Smorgick, Noam ^a   Frenkel, Eugenia ^a   Zaidenstein, Ronit ^a   Lazarovitch, Tsilia ^a   Sherman, Dan J ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Antibiotic treatment; Intra amniotic infection; Ureaplasma urealyticum

Indexed keywords

BETAMETHASONE; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; NIFEDIPINE;

ADULT; AMNIONITIS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; CASE REPORT; CLINICAL FEATURE; DELIVERY; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; FEMALE; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; PHYSICAL EXAMINATION; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; PRURITUS; TRANSVAGINAL ECHOGRAPHY; UREAPLASMA UREALYTICUM;

ACUTE DISEASE; ADULT; AMNIOTIC FLUID; ANTI-BACTERIAL AGENTS; CHORIOAMNIONITIS; CLINDAMYCIN; DRUG THERAPY, COMBINATION; ERYTHROMYCIN; FEMALE; FLUOROQUINOLONES; GESTATIONAL AGE; HUMANS; LIVE BIRTH; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM;

EID: 33847048922     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097103     Document Type: Article

References (14)

1. Gomez R, Romero R, Nien JK, Chaiworapongsa T, Medina L, Kim YM, Yoon BH, Carstens M, Espinoza J, Iams JD, Gonzalez R: A short cervix in women with preterm labor and intact membranes: a risk factor for microbial invasion of the amniotic cavity. Am J Obstet Gynecol 2005;192:678-689.
2. Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R, Sabo V, Athanassiadis AP, Hobbins JC: Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989;161:817-824.
3. Yoon BH, Romero R, Lim JH, Shim SS, Hong JS, Shim JY, Jun JK: The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol 2003;189:919-924.
4. Romero R, Hagay Z, Nores J, Sepulveda W, Mazor M: Eradication of ureaplasma urealyticum from the amniotic fluid with transplacental antibiotic treatment. Am J Obstet Gynecol 1992;166:618-620.
5. Gray DJ, Robinson HB, Malone J, Thomson RB Jr: Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn 1992;12:111-117.
6. Horowitz S, Mazor M, Romero R, Horowitz J, Glezerman M: Infection of the amniotic cavity with Ureaplasma urealyticum in the midtrimester of pregnancy. J Reprod Med 1995;40:375-379.
7. Gerber S, Vial Y, Hohlfeld P, Witkin SS: Detection of Ureaplasma urealyticum in second-trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery. J Infect Dis 2003;187:518-521.
8. Nguyen DP, Gerber S, Hohlfeld P, Sandrine G, Witkin SS: Mycoplasma hominis in mid-trimester amniotic fluid: relation to pregnancy outcome. J Perinat Med 2004;32:323-326.
9. Mazor M, Chaim W, Horowitz S, Leiberman JR, Glezerman M: Successful treatment of preterm labour by eradication of Ureaplasma urealyticum with Erythromycin. Arch Gynecol Obstet 1993;253:215-218.
10. Berg TG, Philpot KL, Welsh MS, Sanger WG, Smith CV: Ureaplasma/ Mycoplasma-infected amniotic fluid: pregnancy outcome in treated and nontreated patients. J Perinatol 1999;19:275-277.
11. Kenny GE, Cartwright FD: Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones. Antimicrob Agents Chemother 2001;45:2604-2608.
12. Heikkinen T, Laine K, Neuvonen PJ, Ekblad U: The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000;107:770-775.
13. Linseman DA, Hampton LA, Branstetter DG: Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin. Fundam Appl Toxicol 1995;28:59-64.
14. Loebstein R, Addis A, Ho E, Andreou R, Sage S, Donnenfeld AE, Schick B, Bonati M, Moretti M, Lalkin A, Pastuszak A, Koren G: Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob Agents Chemother 1998;42:1336-1339.